Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 20, 2026

  1. Minor: RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects Trial completed Ikaria Bioscience Pty LtdPhase 1/2 NCT06471543
  2. Minor: GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab Trial completed NETRIS PharmaPhase 1/2 NCT04652076
  3. Minor: Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab Trial completed Strand Therapeutics Inc.Phase 1/2 NCT06249048
  4. Minor: IMGN632 · Untreated BPDCN and Relapsed/Refractory BPDCN Trial completed AbbViePhase 1/2 NCT03386513
  5. Minor: CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants Trial completed Karuna Therapeutics, Inc., a Bristol Myers Squibb companyPhase 1 NCT07204418
  6. Minor: Ferric Derisomaltose Injection · Iron Deficiency Anemia Under Fasting Conditions Enrollment closed, study ongoing Sichuan Huiyu Pharmaceutical Co., LtdPhase 1 NCT07790562
  7. Minor: Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood Enrollment closed, study ongoing Boehringer IngelheimPhase 1 NCT07781631
  8. Minor: Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants Trial completed Eli Lilly and CompanyPhase 1 NCT07794592
  9. Minor: HLA-G Targeted Exosome (SOB100) in Healthy Subjects Enrollment closed, study ongoing Shine-On Biomedical Co., Ltd.Phase 1 NCT07219940
  10. Minor: Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the Amount of BI 3000202 in the Blood Trial completed Boehringer IngelheimPhase 1 NCT07774325
  11. Minor: LX22001 for Injection in Healthy Subjects Trial status changed: Unknown → Completed Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.Phase 1 NCT06561542
  12. Minor: ²¹²Pb-DOTAM-GRPR1 · Recurrent or Metastatic GRPR-expressing Tumors Enrollment closed, study ongoing Orano Med Theranostics, SASPhase 1 NCT05283330
  13. Minor: ALTUS Powered Stapler Used in Bariatric Surgery Trial status changed: Unknown → Completed Scitech Produtos Medicos SANot specified NCT05642663
  14. Minor: Triton 1.5 Robotic System for Diagnostic Colonoscopy in the Middle East Trial status changed: Not Yet Recruiting → Active, Not Recruiting Neptune MedicalNot applicable NCT07835542
  15. Minor: Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation · Post Intensive Care Syndrome Trial completed POLYSAN Scientific & Technological Pharmaceutical CompanyNot specified NCT06735898
  16. Minor: Citadel Embolization Device Study Trial completed Stryker NeurovascularNot applicable NCT04057352
  17. Minor: BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT Enrollment closed, study ongoing Orchestra BioMed, IncNot applicable NCT06059638
  18. Minor: Real World Adherence of PCSK9 Targeted Therapy Completed without a posted recruiting period Novartis PharmaceuticalsNot specified NCT07468500
  19. Minor: Artoss Prospective Spine Registry Outcomes Trial completed Artoss Inc.Not specified NCT04439032
  20. Minor: Speech Understanding and Listening Effort Benefits of Hearing Instruments Trial completed Sonova AGNot applicable NCT07116135
  21. Minor: Microwave Intervention Under Local Anesthesia Enrollment closed, study ongoing KoelisNot applicable NCT07412275
  22. Minor: Consistency of Response With Rimegepant in Acute Treatment of Migraine Trial completed PfizerNot specified NCT06898047
  23. Minor: Validate the Safety and Performance of the ABLE Kids Device · Neurological Gait Disorders in a Clinical Setting Enrollment closed, study ongoing ABLE Human Motion S.L.Not applicable NCT07745712
  24. Minor: Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension) Trial completed Provention Bio, a Sanofi CompanyNot specified NCT04598893
  25. Minor: Disease Modifying Therapy Use · Multiple Sclerosis Before, During, and After Pregnancy Trial completed Novartis PharmaceuticalsNot specified NCT07844070